Cancers, Vol. 15, Pages 3384: Presence of Myeloid Mutations in Patients with Chronic Myeloid Leukemia Increases Risk of Cardiovascular Event on Tyrosine Kinase Inhibitor Treatment

In conclusion, myeloid mutations detectable at diagnosis increase CVE risk, particularly for patients on imatinib, and might be considered for first-line TKI choice.

Source: Cancers - June 28, 2023 Category: Cancer & Oncology Authors: Ruth Stuckey Adri án Segura-Díaz Mar ía Nieves Sáez Perdomo Manuel Mateo P érez Encinas J óse David González San Miguel Yanira Florido Santiago S ánchez-Sosa Juan Francisco L ópez-Rodríguez Cristina Bilbao-Sieyro Mar ía Teresa Gómez-Casares Tags: Article Source Type: research